IDEAS home Printed from https://ideas.repec.org/f/c/pma1141.html
   My authors  Follow this author

Laura Magazzini

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2010. "The productivity crisis in pharmaceutical R&D," Working Papers 06/2010, University of Verona, Department of Economics.

    Mentioned in:

    1. Why so few drug innovations?
      by Economic Logician in Economic Logic on 2010-09-02 19:25:00

Working papers

  1. Laura Magazzini, 2021. "An LM test for the mean stationarity assumption in dynamic panel-data models," 2021 Stata Conference 8, Stata Users Group.

    Cited by:

    1. Liu, Gordon & Yi, Junjian & Yuan, Ye & Zhao, Shaoyang, 2023. "The short- and long-run effects of medical malpractice lawsuits on medical spending and hospital operations in China," Journal of Comparative Economics, Elsevier, vol. 51(4), pages 1142-1161.

  2. Simona Gamba & Laura Magazzini & Paolo Pertile, 2019. "R&D and market size: who benefits from orphan drug regulation?," Working Papers 09/2019, University of Verona, Department of Economics.

    Cited by:

    1. Massimo FLORIO, 2020. "Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," CIRIEC Working Papers 2008, CIRIEC - Université de Liège.

  3. Bruno, Randolph Luca & Magazzini, Laura & Stampini, Marco, 2019. "Exploiting Information from Singletons in Panel Data Analysis: A GMM Approach," IZA Discussion Papers 12465, Institute of Labor Economics (IZA).

    Cited by:

    1. Jones, Melanie & Kaya, Ezgi, 2022. "The UK Gender Pay Gap: Does Firm Size Matter?," GLO Discussion Paper Series 1149, Global Labor Organization (GLO).
    2. Zaineb Hlioui & Mohamed Gabsi & Abdelwahed Omri, 2022. "Informal Competition Effect on SMEs’ Innovation: Do Credit Constraints Matter? Evidence from Eastern European Countries," Sustainability, MDPI, vol. 14(21), pages 1-23, October.

  4. Giorgio Calzolari & Laura Magazzini, 2014. "Improving GMM efficiency in dynamic models for panel data with mean stationarity," Working Papers 12/2014, University of Verona, Department of Economics.

    Cited by:

    1. Efe Can KILINÇ & Cafer Necat BERBEROĞLU, 2019. "The Relationship Between Saving, Profit Rates and Business CyclesAbstract:There are different approaches of economics schools on the sources, causes and determinants of business cycles. These approach," Sosyoekonomi Journal, Sosyoekonomi Society.

  5. Giorgio Calzolari & Laura Magazzini, 2013. "A powerful test of mean stationarity in dynamic models for panel data: Monte Carlo evidence," Working Papers 14/2013, University of Verona, Department of Economics.

    Cited by:

    1. Tue Gørgens & Chirok Han & Sen Xue, 2019. "Moment Restrictions and Identification in Linear Dynamic Panel Data Models," Annals of Economics and Statistics, GENES, issue 134, pages 149-176.
    2. Giorgio Calzolari & Laura Magazzini, 2014. "Improving GMM efficiency in dynamic models for panel data with mean stationarity," Working Papers 12/2014, University of Verona, Department of Economics.
    3. Tue Gorgens & Chirok Han & Sen Xue, 2016. "Asymptotic distributions of the quadratic GMM estimator in linear dynamic panel data models," ANU Working Papers in Economics and Econometrics 2016-635, Australian National University, College of Business and Economics, School of Economics.

  6. Jing-Yuan Chio & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2012. "The Value of Failures in Pharmaceutical R&D," Working Papers 1/2012, IMT School for Advanced Studies Lucca, revised Jan 2012.

    Cited by:

    1. Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
    2. Rene Belderbos & Victor Gilsing & Shinya Suzuki, 2015. "Direct and mediated ties to universities: ‘Scientific’ absorptive capacity and innovation performance of pharmaceutical firms," Working Papers of Department of Management, Strategy and Innovation, Leuven 504836, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
    3. Ruiz-Conde, Enar & Wieringa, Jaap E. & Leeflang, Peter S.H., 2014. "Competitive diffusion of new prescription drugs: The role of pharmaceutical marketing investment," Technological Forecasting and Social Change, Elsevier, vol. 88(C), pages 49-63.
    4. Gamba, Simona, 2017. "The Effect of Intellectual Property Rights on Domestic Innovation in the Pharmaceutical Sector," World Development, Elsevier, vol. 99(C), pages 15-27.

  7. Giorgio Calzolari & Laura Magazzini, 2011. "Moment Conditions and Neglected Endogeneity in Panel Data Models," Working Papers 02/2011, University of Verona, Department of Economics.

    Cited by:

    1. Laura Magazzini & Giorgio Calzolari, 2012. "Identification of linear panel data models when instruments are not available," Working Papers 06/2012, University of Verona, Department of Economics.
    2. Giorgio Calzolari & Laura Magazzini, 2013. "A powerful test of mean stationarity in dynamic models for panel data: Monte Carlo evidence," Working Papers 14/2013, University of Verona, Department of Economics.

  8. Laura Magazzini & Giorgio Calzolari, 2010. "Negative variance estimates in panel data models," Working Papers 15/2010, University of Verona, Department of Economics.

    Cited by:

    1. Dimitrios Psychoyios & Olympia Missiou & Theologos Dergiades, 2019. "Energy based estimation of the Shadow Economy: The role of Governance Quality," Discussion Paper Series 2019_07, Department of Economics, University of Macedonia, revised Nov 2019.
    2. Xiaobing Le & Xinxin Shao & Kuo Gao, 2023. "The Relationship between Urbanization and Consumption Upgrading of Rural Residents under the Sustainable Development: An Empirical Study Based on Mediation Effect and Threshold Effect," Sustainability, MDPI, vol. 15(10), pages 1-19, May.

  9. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2010. "The productivity crisis in pharmaceutical R&D," Working Papers 06/2010, University of Verona, Department of Economics.

    Cited by:

    1. Francesco Fallucchi & Jan Niederreiter & Massimo Riccaboni, 2021. "Learning and dropout in contests: an experimental approach," Theory and Decision, Springer, vol. 90(2), pages 245-278, March.
    2. Manuel Hermosilla, 2021. "Rushed Innovation: Evidence from Drug Licensing," Management Science, INFORMS, vol. 67(1), pages 257-278, January.
    3. Fumio Teramae & Tomohiro Makino & Yeongjoo Lim & Shintaro Sengoku & Kota Kodama, 2020. "Impact of Research and Development Strategy on Sustainable Growth in Multinational Pharmaceutical Companies," Sustainability, MDPI, vol. 12(13), pages 1-15, July.
    4. Martin Backfisch, 2017. "Have Pharmaceutical R&D Project Success Rates Decreased? A Critical Review and New Empirical Results," MAGKS Papers on Economics 201746, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
    5. Tommaso Ciarli & Andre Lorentz & Marco Valente & Maria Savona, 2017. "Structural Changes and Growth Regime," Working Papers of BETA 2017-19, Bureau d'Economie Théorique et Appliquée, UDS, Strasbourg.
    6. Lorenz, Steffi, 2015. "Diversität und Verbundenheit der unternehmerischen Wissensbasis: Ein neuartiger Messansatz mit Indikatoren aus Innovationsprojekten," Discussion Papers on Strategy and Innovation 15-01, Philipps-University Marburg, Department of Technology and Innovation Management (TIM).
    7. Changhyeon Song & Kwangsoo Shin, 2019. "Business Model Design for Latecomers in Biopharmaceutical Industry: The Case of Korean Firms," Sustainability, MDPI, vol. 11(18), pages 1-15, September.
    8. Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
    9. Levaggi, Rosella, 2014. "Pricing schemes for new drugs: A welfare analysis," Social Science & Medicine, Elsevier, vol. 102(C), pages 69-73.
    10. Martin Backfisch, 2018. "The Development of Firm Size and Innovativeness in the Pharmaceutical industry between 1989 and 2010," MAGKS Papers on Economics 201813, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
    11. Rosella Levaggi & Michele Moretto & Paolo Pertile, 2013. "The dynamics of pharmaceutical regulation and R&D investments," Working Papers 13/2013, University of Verona, Department of Economics.
    12. Rene Belderbos & Victor Gilsing & Shinya Suzuki, 2015. "Direct and mediated ties to universities: ‘Scientific’ absorptive capacity and innovation performance of pharmaceutical firms," Working Papers of Department of Management, Strategy and Innovation, Leuven 504836, KU Leuven, Faculty of Economics and Business (FEB), Department of Management, Strategy and Innovation, Leuven.
    13. Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
    14. Jing-Yuan Chio & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2012. "The Value of Failures in Pharmaceutical R&D," Working Papers 1/2012, IMT School for Advanced Studies Lucca, revised Jan 2012.
    15. Barrenho, E & Smith, PC & Miraldo, M, 2013. "The determinants of attrition in drug development: a duration analysis," Working Papers 12204, Imperial College, London, Imperial College Business School.
    16. Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2012. "I Farmaci Oncologici in Italia: innovazione e sostenibilità economica," Working Papers CERM 02-2012, Competitività, Regole, Mercati (CERM).
    17. Massimo Riccaboni, 2012. "Is There a Productivity Crisis in Pharmaceutical R&D?," Seminar Briefing 000146, Office of Health Economics.
    18. Jobjörnsson, Sebastian & Forster, Martin & Pertile, Paolo & Burman, Carl-Fredrik, 2016. "Late-stage pharmaceutical R&D and pricing policies under two-stage regulation," Journal of Health Economics, Elsevier, vol. 50(C), pages 298-311.
    19. Jing-Yuan Chiou & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2016. "Learning from successes and failures in pharmaceutical R&D," Journal of Evolutionary Economics, Springer, vol. 26(2), pages 271-290, May.
    20. Kaustav Das & Nicolas Klein, 2020. "Do Stronger Patents Lead to Faster Innovation? The Effect of Duplicative Search," Discussion Papers in Economics 20/03, Division of Economics, School of Business, University of Leicester.
    21. Jinhee Kwon & Cheong Kim & Kun Chang Lee, 2020. "Moderating Effect of the Continental Factor on the Business Strategy and M&A Performance in the Pharmaceutical Industry for Sustainable International Business," Sustainability, MDPI, vol. 12(12), pages 1-14, June.
    22. Zuo-Qi Ding & Jian-Ping Ge & Xiao-Ming Wu & Xiao-Nan Zheng, 2013. "Bibliometrics evaluation of research performance in pharmacology/pharmacy: China relative to ten representative countries," Scientometrics, Springer;Akadémiai Kiadó, vol. 96(3), pages 829-844, September.
    23. Jörg Mahlich & Arne Bartol & Srirangan Dheban, 2021. "Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry? - a scenario analysis," Health Economics Review, Springer, vol. 11(1), pages 1-10, December.
    24. Heyoung Yang & Hyuck Jai Lee, 2018. "Long-Term Collaboration Network Based on ClinicalTrials.gov Database in the Pharmaceutical Industry," Sustainability, MDPI, vol. 10(2), pages 1-14, January.
    25. Stephan Eger & Jörg Mahlich, 2014. "Pharmaceutical regulation in Europe and its impact on corporate R&D," Health Economics Review, Springer, vol. 4(1), pages 1-9, December.
    26. Alexandre Trigo, 2016. "Innovation in the Era of Experience: The Changing Role of Users in Healthcare Innovation," Journal of Entrepreneurship, Management and Innovation, Fundacja Upowszechniająca Wiedzę i Naukę "Cognitione", vol. 12(2), pages 29-51.
    27. Magazzini Laura & Fabio Pammolli & Massimo Riccaboni, 2013. "R&D, Within and Between Patent Competition in the Pharmaceutical Industry," Working Papers 3/2013, IMT School for Advanced Studies Lucca, revised Jul 2013.
    28. Fabio Pammolli & Paolo Bonaretti & Massimo Riccaboni & Valentina Tortolini, 2019. "Quali Regole per la Spesa Farmaceutica? - Criticità, Impatti, Proposte," Working Papers CERM 01-2019, Competitività, Regole, Mercati (CERM).

  10. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent Disclosure and R&D Competition in Pharmaceuticals," DISA Working Papers 0902, Department of Computer and Management Sciences, University of Trento, Italy, revised 11 Jun 2009.

    Cited by:

    1. Ding, Haina, 2015. "Innovation strategies and stock price informativeness," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 491, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
    2. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
    3. Acosta, Manuel & Coronado, Daniel & Medina, Jennifer, 2024. "Effects of co-patenting across national boundaries on patent quality. An exploration in pharmaceuticals," MPRA Paper 123322, University Library of Munich, Germany.
    4. Wagner, Stefan & Goossen, Martin C., 2018. "Knowing me, knowing you: inventor mobility and the formation of technology-oriented alliances," IRTG 1792 Discussion Papers 2018-007, Humboldt University of Berlin, International Research Training Group 1792 "High Dimensional Nonstationary Time Series".
    5. Jing-Yuan Chio & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2012. "The Value of Failures in Pharmaceutical R&D," Working Papers 1/2012, IMT School for Advanced Studies Lucca, revised Jan 2012.
    6. Zobel, Ann-Kristin & Lokshin, Boris & Hagedoorn, John, 2016. "Formal and informal appropriation mechanisms: the role of openness and innovativeness," MERIT Working Papers 2016-059, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    7. Jing-Yuan Chiou & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2016. "Learning from successes and failures in pharmaceutical R&D," Journal of Evolutionary Economics, Springer, vol. 26(2), pages 271-290, May.
    8. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2009. "Nuove politiche per l'innovazione nel settore delle scienze della vita," Working Papers CERM 03-2009, Competitività, Regole, Mercati (CERM).

  11. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2009. "Nuove politiche per l'innovazione nel settore delle scienze della vita," Working Papers CERM 03-2009, Competitività, Regole, Mercati (CERM).

    Cited by:

    1. Simona Gamba & Laura Magazzini & Paolo Pertile, 2019. "R&D and market size: who benefits from orphan drug regulation?," Working Papers 09/2019, University of Verona, Department of Economics.

  12. Giorgio Calzolari & Laura Magazzini, 2009. "Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood," Working Papers 53/2009, University of Verona, Department of Economics.

    Cited by:

    1. Millo, Giovanni, 2014. "Maximum likelihood estimation of spatially and serially correlated panels with random effects," Computational Statistics & Data Analysis, Elsevier, vol. 71(C), pages 914-933.
    2. Artūras Juodis, 2018. "Rank based cointegration testing for dynamic panels with fixed T," Empirical Economics, Springer, vol. 55(2), pages 349-389, September.
    3. Pardo Martínez, Clara Inés & Silveira, Semida, 2012. "Analysis of energy use and CO2 emission in service industries: Evidence from Sweden," Renewable and Sustainable Energy Reviews, Elsevier, vol. 16(7), pages 5285-5294.
    4. Pardo Martínez, Clara Inés, 2013. "An analysis of eco-efficiency in energy use and CO2 emissions in the Swedish service industries," Socio-Economic Planning Sciences, Elsevier, vol. 47(2), pages 120-130.

  13. Ashish Arora & Alfonso Gambardella & Laura Magazzini & Fabio Pammolli, 2009. "A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development," KITeS Working Papers 003, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Mar 2009.

    Cited by:

    1. Manuel Hermosilla, 2021. "Rushed Innovation: Evidence from Drug Licensing," Management Science, INFORMS, vol. 67(1), pages 257-278, January.
    2. Ronald Klingebiel & Peter Esser, 2020. "Stage-Gate Escalation," Strategy Science, INFORMS, vol. 5(4), pages 311-329, December.
    3. Timothy Bresnahan & Jonathan Levin, 2012. "Vertical Integration and Market Structure," Discussion Papers 11-010, Stanford Institute for Economic Policy Research.
    4. Kapoor, Rahul & Klueter, Thomas, 2020. "Progress and setbacks: The two faces of technology emergence," Research Policy, Elsevier, vol. 49(1).
    5. Thomas Bolli & Martin Woerter, 2013. "Technological Diversification and Innovation Performance," KOF Working papers 13-336, KOF Swiss Economic Institute, ETH Zurich.
    6. Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
    7. Linde Colen & René Belderbos & Stijn Kelchtermans & Bart Leten, 2024. "Many are called, few are chosen: the role of science in drug development decisions," The Journal of Technology Transfer, Springer, vol. 49(2), pages 492-517, April.
    8. Martin Backfisch, 2017. "Have Pharmaceutical R&D Project Success Rates Decreased? A Critical Review and New Empirical Results," MAGKS Papers on Economics 201746, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
    9. Praag, Mirjam van & Zunino, Diego & Dushnitsky, Gary, 2017. "Badge of Honor or Scarlet Letter? Unpacking Investors’ Judgment of Entrepreneurs’ Past Failure," CEPR Discussion Papers 12329, C.E.P.R. Discussion Papers.
    10. Banerjee, Tannista & Siebert, Ralph, 2017. "Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry," Research Policy, Elsevier, vol. 46(7), pages 1255-1271.
    11. Turanay Caner & Susan K. Cohen & Frits Pil, 2017. "Firm heterogeneity in complex problem solving: A knowledge-based look at invention," Strategic Management Journal, Wiley Blackwell, vol. 38(9), pages 1791-1811, September.
    12. Zunino, Diego & van Praag, Mirjam C. & Dushnitsky, Gary, 2017. "Badge of Honor or Scarlet Letter? Unpacking Investors' Judgment of Entrepreneurs' Past Failure," IZA Discussion Papers 11017, Institute of Labor Economics (IZA).
    13. Leten, Bart & Kelchtermans, Stijn & Belderbos, Ren, 2010. "Internal Basic Research, External Basic Research and the Technological Performance of Pharmaceutical Firms," Working Papers 2010/12, Hogeschool-Universiteit Brussel, Faculteit Economie en Management.
    14. Martin Backfisch, 2018. "The Development of Firm Size and Innovativeness in the Pharmaceutical industry between 1989 and 2010," MAGKS Papers on Economics 201813, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
    15. Gaessler, Fabian & Wagner, Stefan, 2019. "Patents, Data Exclusivity, and the Development of New Drugs," Rationality and Competition Discussion Paper Series 176, CRC TRR 190 Rationality and Competition.
    16. Fabio Pammolli & Massimo Riccaboni & Alessandro Spelta, 2021. "The network origins of Schumpeterian innovation," Journal of Evolutionary Economics, Springer, vol. 31(5), pages 1411-1431, November.
    17. Jack Scannell & Bruno Versaevel & Etienne Billette de Villemeur, 2022. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," Post-Print hal-03967759, HAL.
    18. Ute Laermann-Nguyen & Martin Backfisch, 2021. "Innovation crisis in the pharmaceutical industry? A survey," SN Business & Economics, Springer, vol. 1(12), pages 1-37, December.
    19. Ashish Arora & Michelle Gittelman & Sarah Kaplan & John Lynch & Will Mitchell & Nicolaj Siggelkow & Denisa Mindruta & Mahka Moeen & Rajshree Agarwal, 2016. "A two-sided matching approach for partner selection and assessing complementarities in partners' attributes in inter-firm alliances," Strategic Management Journal, Wiley Blackwell, vol. 37(1), pages 206-231, January.
    20. Ashish Arora & Michelle Gittelman & Sarah Kaplan & John Lynch & Will Mitchell & Nicolaj Siggelkow & Deepa Mani & Anand Nandkumar, 2016. "The differential impacts of markets for technology on the value of technological resources: An application of group-based trajectory models," Strategic Management Journal, Wiley Blackwell, vol. 37(1), pages 192-205, January.
    21. Henry Sauermann, 2017. "Fire in the Belly? Employee Motives and Innovative Performance in Startups versus Established Firms," NBER Working Papers 23099, National Bureau of Economic Research, Inc.
    22. K D S Fernald & H P G Pennings & J F van den Bosch & H R Commandeur & E Claassen, 2017. "The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance," PLOS ONE, Public Library of Science, vol. 12(2), pages 1-22, February.
    23. Hong Luo, 2014. "When to Sell Your Idea: Theory and Evidence from the Movie Industry," Management Science, INFORMS, vol. 60(12), pages 3067-3086, December.
    24. Eder, Andreas, 2017. "Cost efficiency and economies of diversification of biogas-fuelled cogeneration plants in Austria: a nonparametric approach," MPRA Paper 80369, University Library of Munich, Germany.
    25. Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
    26. Kristina McElheran, 2015. "Do Market Leaders Lead in Business Process Innovation? The Case(s) of E-business Adoption," Management Science, INFORMS, vol. 61(6), pages 1197-1216, June.
    27. Ye, Guangliang & Mukhopadhyay, Samar K., 2013. "Role of demand-side strategy in quality competition," International Journal of Production Economics, Elsevier, vol. 145(2), pages 696-701.
    28. Alfonso Gambardella & Martin Ganco & Florence Honoré, 2015. "Using What You Know: Patented Knowledge in Incumbent Firms and Employee Entrepreneurship," Organization Science, INFORMS, vol. 26(2), pages 456-474, April.
    29. Brandon Pope & Andrew Johnson, 2013. "Returns to scope: a metric for production synergies demonstrated for hospital production," Journal of Productivity Analysis, Springer, vol. 40(2), pages 239-250, October.
    30. Gaurab Aryal & Federico Ciliberto & Leland E. Farmer & Ekaterina Khmelnitskaya, 2022. "Valuing Pharmaceutical Drug Innovations," Papers 2212.07384, arXiv.org, revised Apr 2024.
    31. Messeni Petruzzelli, Antonio & Ardito, Lorenzo & Savino, Tommaso, 2018. "Maturity of knowledge inputs and innovation value: The moderating effect of firm age and size," Journal of Business Research, Elsevier, vol. 86(C), pages 190-201.
    32. Annapoornima M. Subramanian & Moren Lévesque & Vareska van de Vrande, 2020. "“Pulling the Plug:” Time Allocation between Drug Discovery and Development Projects," Production and Operations Management, Production and Operations Management Society, vol. 29(12), pages 2851-2876, December.
    33. Bhawani Bhatnagar & Viktor Dörfler & Jillian MacBryde, 2023. "Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries," The Journal of Technology Transfer, Springer, vol. 48(6), pages 2204-2248, December.
    34. Becker, Annette & Hottenrott, Hanna & Mukherjee, Anwesha, 2022. "Division of labor in R&D? Firm size and specialization in corporate research," Journal of Economic Behavior & Organization, Elsevier, vol. 194(C), pages 1-23.
    35. Asif Khan & Sughra Bibi & Jiaying Lyu & Achille Claudio Garavelli & Pierpaolo Pontrandolfo & Maria de Angeles Perez Sanchez, 2020. "Uncovering Innovativeness in Spanish Tourism Firms: The Role of Transformational Leadership, OCB, Firm Size, and Age," Sustainability, MDPI, vol. 12(10), pages 1-26, May.
    36. Thomas Maximilian Klueter & Solon Moreira & Clinton Ofoedu, 2024. "Understanding the Link between Post‐Acquisition Resource Reconfiguration and Technology Out‐Licensing," Journal of Management Studies, Wiley Blackwell, vol. 61(5), pages 2101-2136, July.
    37. Tannista Banerjee & Ralph Siebert, 2017. "The Impact of R&D Cooperations and Mergers in Pharmaceuticals on Research Activities and Drugs Offered on the Market," Southern Economic Journal, John Wiley & Sons, vol. 84(1), pages 202-228, July.
    38. Santoro, Gabriele & Mazzoleni, Alberto & Quaglia, Roberto & Solima, Ludovico, 2021. "Does age matter? The impact of SMEs age on the relationship between knowledge sourcing strategy and internationalization," Journal of Business Research, Elsevier, vol. 128(C), pages 779-787.
    39. Arora, Ashish & Gambardella, Alfonso, 2010. "The Market for Technology," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 641-678, Elsevier.

  14. Pammolli, Fabio & Riccaboni, Massimo & Magazzini, Laura, 2008. "The Sustainability of European Health Care Systems: Beyond Income and Ageing," MPRA Paper 16026, University Library of Munich, Germany.

    Cited by:

    1. Mihaela Tofan & Mihaela Onofrei & Anca-Florentina Vatamanu, 2020. "Fiscal Responsibility Legal Framework—New Paradigm for Fiscal Discipline in the EU," Risks, MDPI, vol. 8(3), pages 1-18, July.
    2. Lakomaa, Erik & Sanandaji, Tino, 2017. "Integrating community driven care service in European welfare states – nonprofit institutional entrepreneurship as driver for expanding access," SSE Working Paper Series in Economic History 2017:5, Stockholm School of Economics.
    3. Rocco Palumbo, 2020. "Improving Health Professionals’ Involvement Whilst Sustaining Work–Life Balance: Evidence from an Empirical Analysis," Sustainability, MDPI, vol. 12(21), pages 1-21, November.
    4. Michael Osti & Johannes Steyrer, 2017. "A perspective on the health care expenditures for defensive medicine," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(4), pages 399-404, May.
    5. Pammolli, Fabio & Salerno, Nicola, 2011. "Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM [Regional differences in the governance of health care expenditure," MPRA Paper 36934, University Library of Munich, Germany.
    6. Renuga Nagarajan & Aurora A.C. Teixeira & Sandra T. Silva, 2013. "The impact of population ageing on economic growth: an in-depth bibliometric analysis," FEP Working Papers 505, Universidade do Porto, Faculdade de Economia do Porto.
    7. Sónia Morgado, 2014. "Does health promote economic growth? Portuguese case study: from dictatorship to full democracy," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(6), pages 591-598, July.
    8. Allen, Nicola & Pichler, Franz & Wang, Tina & Patel, Sundip & Salek, Sam, 2013. "Development of archetypes for non-ranking classification and comparison of European National Health Technology Assessment systems," Health Policy, Elsevier, vol. 113(3), pages 305-312.
    9. Héctor Bellido & Lorena Olmos & Juan Antonio Román-Aso, 2019. "Do political factors influence public health expenditures? Evidence pre- and post-great recession," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(3), pages 455-474, April.
    10. Carla Blazquez-Fernandez & David Cantarero & Patricio Perez, 2014. "Disentangling the heterogeneous income elasticity and dynamics of health expenditure," Applied Economics, Taylor & Francis Journals, vol. 46(16), pages 1839-1854, June.
    11. Sanandaji, Tino & Lakomaa, Erik, 2016. "Care, Commons and Entrepreneurship," SSE Working Paper Series in Economic History 2016:2, Stockholm School of Economics.
    12. Di Matteo, Livio & Cantarero-Prieto, David, 2018. "The Determinants of Public Health Expenditures: Comparing Canada and Spain," MPRA Paper 87800, University Library of Munich, Germany.
    13. José Villaverde & Adolfo Maza & María Hierro, 2014. "Health care expenditure disparities in the European Union and underlying factors: a distribution dynamics approach," International Journal of Health Economics and Management, Springer, vol. 14(3), pages 251-268, September.
    14. José Castillo-Manzano & Mercedes Castro-Nuño & Xavier Fageda, 2014. "Can health public expenditure reduce the tragic consequences of road traffic accidents? The EU-27 experience," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(6), pages 645-652, July.
    15. Renuga Nagarajan & Aurora A. C. Teixeira & Sandra Silva, 2017. "The Impact Of Population Ageing On Economic Growth: A Bibliometric Survey," The Singapore Economic Review (SER), World Scientific Publishing Co. Pte. Ltd., vol. 62(02), pages 275-296, June.
    16. Lakomaa, Erik & Sanandaji, Tino, 2017. "Can Community Driven Care be integrated in the European Welfare System? Institutional Challenges and Historical Lessons," SSE Working Paper Series in Economic History 2017:3, Stockholm School of Economics.
    17. Fabio Pammolli & Nicola Carmine Salerno, 2011. "Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011," Working Papers CERM 02-2011, Competitività, Regole, Mercati (CERM).
    18. Munjae Lee & Sewon Park & Kyu-Sung Lee, 2019. "What Are the Features of Successful Medical Device Start-Ups? Evidence from KOREA," Sustainability, MDPI, vol. 11(7), pages 1-17, April.
    19. Kirsten Beedholm & Kirsten Frederiksen & Anne‐Marie Skovsgaard Frederiksen & Kirsten Lomborg, 2015. "Attitudes to a robot bathtub in Danish elder care: A hermeneutic interview study," Nursing & Health Sciences, John Wiley & Sons, vol. 17(3), pages 280-286, September.
    20. Joohun Han & Chanjin Chung, 2021. "Impact of Aging and Underemployment on Income Disparity between Agricultural and Non-Agricultural Households," Sustainability, MDPI, vol. 13(21), pages 1-15, October.

  15. Chiara Bonassi & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2007. "La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale," Working Papers CERM 03-2007, Competitività, Regole, Mercati (CERM).

    Cited by:

    1. Pammolli, Fabio & Salerno, Nicola, 2011. "Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM [Regional differences in the governance of health care expenditure," MPRA Paper 36934, University Library of Munich, Germany.
    2. Fiorio, Carlo V. & Siciliani, Luigi, 2010. "Co-payments and the demand for pharmaceuticals: Evidence from Italy," Economic Modelling, Elsevier, vol. 27(4), pages 835-841, July.
    3. Fabio Pammolli & Nicola Carmine Salerno, 2011. "Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011," Working Papers CERM 02-2011, Competitività, Regole, Mercati (CERM).
    4. Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2009. "La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio," Working Papers CERM 02-2009, Competitività, Regole, Mercati (CERM).

  16. Harhoff, Dietmar & Garcia-Fontes, Walter & Gambardella, Alfonso & Giuri, Paola & Mariani, Myriam & Luzzi, Alessandra & Brusoni, Stefano & , & Francoz, Dominique & Geuna, Aldo & Gonzales, Raul & Hoisl,, 2006. "Everything You Always Wanted to Know about Inventors (But Never Asked): Evidence from the PatVal-EU Survey," CEPR Discussion Papers 5752, C.E.P.R. Discussion Papers.

    Cited by:

    1. Frey, Rainer & Hussinger, Katrin, 2006. "The Role of Technology in M&As: A Firm Level Comparison of Cross-Border and Domestic Deals," ZEW Discussion Papers 06-069, ZEW - Leibniz Centre for European Economic Research.
    2. Nicolas van Zeebroeck, 2011. "The puzzle of patent value indicators," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 20(1), pages 33-62.
    3. Nobuya Fukugawa, 2013. "University spillovers into small technology-based firms: channel, mechanism, and geography," The Journal of Technology Transfer, Springer, vol. 38(4), pages 415-431, August.
    4. Nicolas van Zeebroeck, 2007. "Patents only live twice: a patent survival analysis in Europe," Working Papers CEB 07-028.RS, ULB -- Universite Libre de Bruxelles.
    5. Koehler, Mila & Peters, Bettina, 2017. "Subsidized and non-subsidized R&D projects: Do they differ?," ZEW Discussion Papers 17-042, ZEW - Leibniz Centre for European Economic Research.
    6. ONISHI Koichiro & OWAN Hideo & NAGAOKA Sadao, 2015. "Monetary Incentives for Corporate Inventors: Intrinsic motivation, project selection and inventive performance," Discussion papers 15071, Research Institute of Economy, Trade and Industry (RIETI).
    7. Rockett, Katharine, 2010. "Property Rights and Invention," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 315-380, Elsevier.
    8. Nikulainen, Tuomo, . "Studies on the Diffusion of New Science Based Technologies," ETLA A, The Research Institute of the Finnish Economy, number 45, June.
    9. Hossain, Mokter & Simula, Henri, 2017. "Recycling the unused ideas and technologies of a large corporation into new business by start-ups," Technology in Society, Elsevier, vol. 48(C), pages 11-18.
    10. FUKUGAWA Nobuya, 2023. "Determinants of Commercialization Modes of Science: Evidence from panel data of university technology transfer in Japan," Discussion papers 23053, Research Institute of Economy, Trade and Industry (RIETI).
    11. FUKUGAWA Nobuya, 2016. "Knowledge Creation and Dissemination by Local Public Technology Centers in Regional and Sectoral Innovation Systems: Insights from patent data," Discussion papers 16061, Research Institute of Economy, Trade and Industry (RIETI).
    12. Camilla Lenzi, 2009. "Patterns and determinants of skilled workers' mobility: evidence from a survey of Italian inventors," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(2), pages 161-179.
    13. Neus Palomeras, 2007. "An Analysis of Pure‐Revenue Technology Licensing," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 16(4), pages 971-994, December.
    14. Bart Verspagen, 2006. "University research, intellectual property rights and European innovation systems," Working Papers 06-05, Eindhoven Center for Innovation Studies, revised Mar 2006.
    15. Fukugawa, Nobuya, 2012. "Impacts of intangible assets on the initial public offering of biotechnology startups," Economics Letters, Elsevier, vol. 116(1), pages 83-85.
    16. Simona Tenaglia & Marco Ventura, 2008. "Valuing environmental patents legal protection when data is not available," ISAE Working Papers 103, ISTAT - Italian National Institute of Statistics - (Rome, ITALY).
    17. Mafini Dosso & Didier Lebert, 2019. "A geography of corporate knowledge flows across world regions: evidence from patent citations of top R&D-investing firms," JRC Working Papers on Corporate R&D and Innovation 2019-03, Joint Research Centre.
    18. Gustavo Crespi & Aldo Geuna & Lionel Nesta, 2007. "The mobility of university inventors in Europe," The Journal of Technology Transfer, Springer, vol. 32(3), pages 195-215, June.
    19. Gustavo A. Crespi & Aldo Geuna & Bart Verspagen, 2007. "University IPRs and Knowledge Transfer. Is the IPR ownership model more efficient?," ICER Working Papers 02-2007, ICER - International Centre for Economic Research.
    20. Grid Thoma & Salvatore Torrisi, 2007. "Creating Powerful Indicators for Innovation Studies with Approximate Matching Algorithms. A test based on PATSTAT and Amadeus databases," KITeS Working Papers 211, KITeS, Centre for Knowledge, Internationalization and Technology Studies, Universita' Bocconi, Milano, Italy, revised Dec 2007.
    21. Gambardella, Alfonso & Giuri, Paola & Luzzi, Alessandra, 2007. "The market for patents in Europe," Research Policy, Elsevier, vol. 36(8), pages 1163-1183, October.
    22. Myriam Mariani & Marzia Romanelli, 2006. ""Stacking" or "Picking" Patents? The Inventors' Choice Between Quantity and Quality," LEM Papers Series 2006/06, Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy.
    23. Harhoff, Dietmar & Hoisl, Karin, 2007. "Institutionalized incentives for ingenuity--Patent value and the German Employees' Inventions Act," Research Policy, Elsevier, vol. 36(8), pages 1143-1162, October.
    24. Marco, Antonio De & Scellato, Giuseppe & Ughetto, Elisa & Caviggioli, Federico, 2017. "Global markets for technology: Evidence from patent transactions," Research Policy, Elsevier, vol. 46(9), pages 1644-1654.
    25. Isabelle Liotard, 2007. "Les nouvelles facettes de la propriété intellectuelle : stratégies, attaques et menaces," Post-Print hal-00196848, HAL.
    26. Sebastien Lechevalier & Yukio Ikeda & Junichi Nishimura, 2006. "Collaborative R&D in the robot technology in Japan: an inquiry based on patent data analysis (1991-2004)," CIRJE F-Series CIRJE-F-453, CIRJE, Faculty of Economics, University of Tokyo.
    27. Hosein Fallah, M. & Choudhury, Piyasi & Daim, Tugrul U., 2012. "Does movement of inventors between companies affect their productivity?," Technology in Society, Elsevier, vol. 34(3), pages 196-206.
    28. Petra Moser, 2012. "Innovation without Patents: Evidence from World's Fairs," Journal of Law and Economics, University of Chicago Press, vol. 55(1), pages 43-74.
    29. Henseke, Golo & Tivig, Thusnelda, 2007. "Demographic change and industry-specific innovation patterns in Germany," Thuenen-Series of Applied Economic Theory 72, University of Rostock, Institute of Economics.
    30. Nobuya Fukugawa, 2011. "Impacts and channels of university spillovers before the national innovation system reform in Japan," International Journal of Transitions and Innovation Systems, Inderscience Enterprises Ltd, vol. 1(4), pages 383-393.

  17. Gianluca Baio & Laura Magazzini & Claudia Oglialoro & Fabio Pammolli & Massimo Riccaboni, 2005. "Medical Devices: Competitiveness and Impact on Public Health Expenditure," Working Papers CERM 05-2005, Competitività, Regole, Mercati (CERM).

    Cited by:

    1. Kurt Hornschild & Stephan Raab & Jörg-Peter Weiß, 2005. "Die Medizintechnik am Standort Deutschland: Chancen und Risiken durch technologische Innovationen, Auswirkungen auf und durch das nationale Gesundheitssystem sowie potentielle Wachstumsmärkte im Ausla," DIW Berlin: Politikberatung kompakt, DIW Berlin, German Institute for Economic Research, edition 2, volume 10, number pbk10, April.
    2. G. Crea & A. Cavaliere & A. Cozzi, 2019. "Price discrimination in the Italian medical device industry: an empirical analysis," Economia Politica: Journal of Analytical and Institutional Economics, Springer;Fondazione Edison, vol. 36(2), pages 571-608, July.
    3. Martino Maggetti & Christian Ewert & Philipp Trein, 2017. "Not Quite the Same," The ANNALS of the American Academy of Political and Social Science, , vol. 670(1), pages 152-169, March.
    4. Steven Simoens, 2009. "Which barriers prevent the efficient use of resources in medical device sectors?," Applied Health Economics and Health Policy, Springer, vol. 7(4), pages 209-217, December.
    5. Peter Willemé & Michel Dumont, 2016. "Machines that go ‘ping’: Medical Technology and Health Expenditures in OECD Countries," Health Economics, John Wiley & Sons, Ltd., vol. 25(3), pages 387-388, March.
    6. Davide Consoli & Andrea Mina, 2009. "An evolutionary perspective on health innovation systems," Journal of Evolutionary Economics, Springer, vol. 19(2), pages 297-319, April.
    7. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2008. "The Sustainability of European Health Care Systems: Beyond Income and Ageing," Working Papers 52/2008, University of Verona, Department of Economics.
    8. Kamil Dybczak & Bartosz Przywara, 2010. "The role of technology in health care expenditure in the EU," European Economy - Economic Papers 2008 - 2015 400, Directorate General Economic and Financial Affairs (DG ECFIN), European Commission.
    9. Shelley McDonough Kimelberg & Lauren A. Nicoll, 2012. "Business Location Decisions in the Medical Device Industry," Economic Development Quarterly, , vol. 26(1), pages 34-49, February.
    10. Fabio Pammolli & Nicola Carmine Salerno, 2006. "Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine," Working Papers CERM 02-2006, Competitività, Regole, Mercati (CERM).
    11. D. Ackerly & Seth Glickman & Kevin Schulman, 2010. "Economic Content in Medical Journal Advertisements for Medical Devices and Prescription Drugs," PharmacoEconomics, Springer, vol. 28(5), pages 429-438, May.
    12. Galizzi, Matteo M. & Miraldo, Marisa, 2011. "The effects of hospitals' governance on optimal contracts: Bargaining vs. contracting," Journal of Health Economics, Elsevier, vol. 30(2), pages 408-424, March.
    13. Elisabet Rodriguez Llorian & Janelle Mann, 2022. "Exploring the technology–healthcare expenditure nexus: a panel error correction approach," Empirical Economics, Springer, vol. 62(6), pages 3061-3086, June.
    14. Monica Plechero & Claudio Cozza & Raquel Ortega-Argiles, 2017. "European Disparities in Regional Health R&I Performance," Working Papers 13, Venice School of Management - Department of Management, Università Ca' Foscari Venezia.
    15. Viktor Chuzhykov & Areg Movsesyan, 2020. "Peculiarities of the Ukrainian medical device market," Business Management, D. A. Tsenov Academy of Economics, Svishtov, Bulgaria, issue 2 Year 20, pages 25-37.

  18. Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo, 2004. "Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure," MPRA Paper 15968, University Library of Munich, Germany.

    Cited by:

    1. Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2005. "Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN," Working Papers CERM 01-2005, Competitività, Regole, Mercati (CERM).
    2. Patricia Laurens & Christian Le Bas & Antoine Schoen, 2019. "Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?," Post-Print hal-01725229, HAL.
    3. Patricia M. Danzon & Michael F. Furukawa, 2011. "Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets," NBER Working Papers 17226, National Bureau of Economic Research, Inc.
    4. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Papers in Economics 11476, University of Munich, Department of Economics.
    5. Carl Blankart & Tom Stargardt & Jonas Schreyögg, 2011. "Availability of and Access to Orphan Drugs," PharmacoEconomics, Springer, vol. 29(1), pages 63-82, January.
    6. Gonzalez, Jorge & Sismeiro, Catarina & Dutta, Shantanu & Stern, Philip, 2008. "Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules," International Journal of Research in Marketing, Elsevier, vol. 25(4), pages 247-260.
    7. Akaleephan, Chutima & Wibulpolprasert, Suwit & Sakulbumrungsil, Rungpetch & Luangruangrong, Paithip & Jitraknathee, Anchalee & Aeksaengsri, Achara & Udomaksorn, Siripa & Tangcharoensathien, Viroj & Ta, 2009. "Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: Analysis of the effect of TRIPs-Plus proposal," Health Policy, Elsevier, vol. 91(2), pages 174-182, July.
    8. Costa-i-Font, Joan & Varol, Nebibe & McGuire, Alistair, 2011. "Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008," LSE Research Online Documents on Economics 37537, London School of Economics and Political Science, LSE Library.
    9. Costa-Font, Joan & McGuire, Alistair & Varol, Nebibe, 2014. "Price regulation and relative delays in generic drug adoption," Journal of Health Economics, Elsevier, vol. 38(C), pages 1-9.
    10. Birg, Laura, 2013. "Pharmaceutical regulation and health policy objectives," University of Göttingen Working Papers in Economics 183, University of Goettingen, Department of Economics.
    11. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 357, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
    12. Gonzalez, Jorge & Sismeiro, Catarina & Dutta, Shantanu & Stern, Philip, 2006. "Market Effects of Generic Entry: The Role of Physicians and of Non-Bioequivalent Competitors," MPRA Paper 3717, University Library of Munich, Germany, revised May 2007.
    13. Pieter Dylst & Steven Simoens, 2011. "Does the Market Share of Generic Medicines Influence the Price Level?," PharmacoEconomics, Springer, vol. 29(10), pages 875-882, October.
    14. Gianni Amisano & Maria Letizia Giorgetti, 2013. "Entry Into Pharmaceutical Submarkets: A Bayesian Panel Probit Analysis," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 28(4), pages 667-701, June.
    15. Iván Moreno-Torres & Jaume Puig-Junoy & Joan-Ramon Borrell, 2009. "Generic Entry into the Regulated Spanish Pharmaceutical Market," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 34(4), pages 373-388, June.
    16. Leopold, Christine & Mantel-Teeuwisse, Aukje Katja & Vogler, Sabine & de Joncheere, Kees & Laing, Richard Ogilvie & Leufkens, Hubert G.M., 2013. "Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries," Health Policy, Elsevier, vol. 112(3), pages 209-216.
    17. Magazzini Laura & Fabio Pammolli & Massimo Riccaboni, 2013. "R&D, Within and Between Patent Competition in the Pharmaceutical Industry," Working Papers 3/2013, IMT School for Advanced Studies Lucca, revised Jul 2013.
    18. Crowe, Bronwyn & Lindner, Bob & Llewellyn, Rick, 2006. "The benefits and beneficiaries of “public” investment in herbicide use research and development," 2006 Conference (50th), February 8-10, 2006, Sydney, Australia 174476, Australian Agricultural and Resource Economics Society.
    19. Jim Attridge, 2007. "Innovation Models In The Biopharmaceutical Sector," International Journal of Innovation Management (ijim), World Scientific Publishing Co. Pte. Ltd., vol. 11(02), pages 215-243.

  19. Calzolari, Giorgio & Magazzini, Laura & Mealli, Fabrizia, 2001. "Simulation-based estimation of Tobit model with random effects," MPRA Paper 22985, University Library of Munich, Germany, revised 2001.

    Cited by:

    1. Luca Romagnoli & Vincenzo Giaccio & Luigi Mastronardi & Maria Bonaventura Forleo, 2021. "Highlighting the Drivers of Italian Diversified Farms Efficiency: A Two-Stage DEA-Panel Tobit Analysis," Sustainability, MDPI, vol. 13(23), pages 1-16, November.
    2. Daniela Campus & Gianna Giannelli, 2016. "Is the Allocation of Time Gender Sensitive to Food Price Changes? An Investigation of Hours of Work in Uganda," Working Papers - Economics wp2016_16.rdf, Universita' degli Studi di Firenze, Dipartimento di Scienze per l'Economia e l'Impresa.
    3. Campus, Daniela, 2017. "Gender differentials in agricultural productivity: an empirical evidence from Uganda," 2017 Sixth AIEAA Conference, June 15-16, Piacenza, Italy 261259, Italian Association of Agricultural and Applied Economics (AIEAA).
    4. Geoffrey Norman Tumwine & Razack B Lokina & John Mary Matovu, 2019. "The Effect of Climate Change on Agricultural Crop Returns in Uganda," Journal of Economics and Behavioral Studies, AMH International, vol. 11(4), pages 71-87.

Articles

  1. Laura Magazzini & Giorgio Calzolari, 2023. "A Lagrange multiplier test for the mean stationarity assumption in dynamic panel-data models," Stata Journal, StataCorp LP, vol. 23(2), pages 418-437, June.

    Cited by:

    1. Moritz Wolf, 2024. "The impact of G7 trade policies on economic development in Africa," Jena Economics Research Papers 2024-005, Friedrich-Schiller-University Jena.

  2. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).

    Cited by:

    1. Massimo FLORIO, 2020. "Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," CIRIEC Working Papers 2008, CIRIEC - Université de Liège.
    2. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    3. Blind, Knut, 2024. "The role of the quality infrastructure within socio-technical transformations: A European perspective," Technological Forecasting and Social Change, Elsevier, vol. 199(C).

  3. Giorgio Calzolari & Maria Gabriella Campolo & Antonino Di Pino & Laura Magazzini, 2021. "Maximum likelihood estimation of an across-regime correlation parameter," Stata Journal, StataCorp LP, vol. 21(2), pages 430-461, June.

    Cited by:

    1. Giorgio Calzolari & Maria Gabriella Campolo & Antonino Pino & Laura Magazzini, 2023. "Assessing individual skill influence on housework time of Italian women: an endogenous-switching approach," Statistical Methods & Applications, Springer;Società Italiana di Statistica, vol. 32(2), pages 659-679, June.

  4. Bruno, Randolph Luca & Magazzini, Laura & Stampini, Marco, 2020. "Exploiting information from singletons in panel data analysis: A GMM approach," Economics Letters, Elsevier, vol. 186(C).
    See citations under working paper version above.
  5. Laura Magazzini & Giorgio Calzolari, 2019. "Testing initial conditions in dynamic panel data models," Econometric Reviews, Taylor & Francis Journals, vol. 39(2), pages 115-134, December.

    Cited by:

    1. Hossain, Mohammed Sawkat, 2021. "A revisit of capital structure puzzle: Global evidence and analysis," International Review of Economics & Finance, Elsevier, vol. 75(C), pages 657-678.
    2. Liu, Gordon & Yi, Junjian & Yuan, Ye & Zhao, Shaoyang, 2023. "The short- and long-run effects of medical malpractice lawsuits on medical spending and hospital operations in China," Journal of Comparative Economics, Elsevier, vol. 51(4), pages 1142-1161.

  6. Jing-Yuan Chiou & Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2016. "Learning from successes and failures in pharmaceutical R&D," Journal of Evolutionary Economics, Springer, vol. 26(2), pages 271-290, May.

    Cited by:

    1. Linde Colen & René Belderbos & Stijn Kelchtermans & Bart Leten, 2024. "Many are called, few are chosen: the role of science in drug development decisions," The Journal of Technology Transfer, Springer, vol. 49(2), pages 492-517, April.
    2. Mike Thelwall & Kayvan Kousha, 2016. "Are citations from clinical trials evidence of higher impact research? An analysis of ClinicalTrials.gov," Scientometrics, Springer;Akadémiai Kiadó, vol. 109(2), pages 1341-1351, November.
    3. Qun Chen & Ji-Wen Li & Jian-Guo Liu & Jing-Ti Han & Yun Shi & Xun-Hua Guo, 2021. "Borrower Learning Effects: Do Prior Experiences Promote Continuous Successes in Peer-to-Peer Lending?," Information Systems Frontiers, Springer, vol. 23(4), pages 963-986, August.
    4. Qun Chen & Ji-Wen Li & Jian-Guo Liu & Jing-Ti Han & Yun Shi & Xun-Hua Guo, 0. "Borrower Learning Effects: Do Prior Experiences Promote Continuous Successes in Peer-to-Peer Lending?," Information Systems Frontiers, Springer, vol. 0, pages 1-24.
    5. Belderbos, René & Leten, Bart & Suzuki, Shinya, 2023. "International R&D and MNCs' innovation performance: An integrated approach," Journal of International Management, Elsevier, vol. 29(6).

  7. Emanuele Giovannetti & Laura Magazzini, 2013. "Resale Price Maintenance: An Empirical Analysis of UK Firms' Compliance," Economic Journal, Royal Economic Society, vol. 123(11), pages 582-595, November.

    Cited by:

    1. Xulia González, 2015. "Empirical Regularities in the Vertical Restraints of Manuacturing Firms," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 43(2), pages 181-194, June.

  8. Giorgio Calzolari & Laura Magazzini, 2012. "Autocorrelation and masked heterogeneity in panel data models estimated by maximum likelihood," Empirical Economics, Springer, vol. 43(1), pages 145-152, August.
    See citations under working paper version above.
  9. Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2012. "The sustainability of European health care systems: beyond income and aging," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 623-634, October.
    See citations under working paper version above.
  10. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni & Maria Alessandra Rossi, 2009. "Patent disclosure and R&D competition in pharmaceuticals," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 467-486.
    See citations under working paper version above.
  11. Ashish Arora & Alfonso Gambardella & Laura Magazzini & Fabio Pammolli, 2009. "A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development," Management Science, INFORMS, vol. 55(10), pages 1638-1653, October.
    See citations under working paper version above.
  12. Giuri, Paola & Mariani, Myriam & Brusoni, Stefano & Crespi, Gustavo & Francoz, Dominique & Gambardella, Alfonso & Garcia-Fontes, Walter & Geuna, Aldo & Gonzales, Raul & Harhoff, Dietmar & Hoisl, Karin, 2007. "Inventors and invention processes in Europe: Results from the PatVal-EU survey," Research Policy, Elsevier, vol. 36(8), pages 1107-1127, October.

    Cited by:

    1. Riccardo Crescenzi & Max Nathan & Andrés Rodríguez-Pose, 2014. "Do Inventors Talk to Strangers? On Proximity and Collaborative Knowledge Creation," SERC Discussion Papers 0153, Centre for Economic Performance, LSE.
    2. Enkel, Ellen & Heil, Sebastian & Hengstler, Monika & Wirth, Henning, 2017. "Exploratory and exploitative innovation: To what extent do the dimensions of individual level absorptive capacity contribute?," Technovation, Elsevier, vol. 60, pages 29-38.
    3. Knut Blind & Florian Ramel & Charlotte Rochell, 2022. "The influence of standards and patents on long-term economic growth," The Journal of Technology Transfer, Springer, vol. 47(4), pages 979-999, August.
    4. Jan-Bart Vervenne & Julie Callaert & Machteld Hoskens & Bart Looy, 2022. "To what extent do SMEs contribute to Europe’s patent stock? A methodological outline for creating a Europe-wide SME technology indicator," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(6), pages 3049-3082, June.
    5. Athreye, Suma & Fassio, Claudio & Roper, Stephen, 2020. "Small firms and patenting revisited," Papers in Innovation Studies 2020/2, Lund University, CIRCLE - Centre for Innovation Research.
    6. Schettino, Francesco & Sterlacchini, Alessandro & Venturini, Francesco, 2008. "Inventive Productivity and Patent Quality: Evidence from Italian Inventors," MPRA Paper 7765, University Library of Munich, Germany.
    7. Frosch, Katharina & Harhoff, Dietmar & Hoisl, Karin & Steinle, Christian & Zwick, Thomas, 2015. "Individual determinants of inventor productivity: Report and preliminary results with evidence from linked human capital and patent data," ZEW Discussion Papers 15-001, ZEW - Leibniz Centre for European Economic Research.
    8. Cédric Schneider, 2009. "External knowledge sourcing: science, market and the value of patented inventions," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 30(8), pages 551-560.
    9. Alessandra Venturini, Fabio Montobbio and Claudio Fassi, 2012. "Are Migrants Spurring Innovation?," RSCAS Working Papers 2012/11, European University Institute.
    10. Wang, P.E.N.G.F.E.I., 2024. "Pricing innovation: The anchoring effect in patent valuation," Technovation, Elsevier, vol. 136(C).
    11. Ufuk Akcigit & Salomé Baslandze & Stefanie Stantcheva, 2015. "Taxation and the International Mobility of Inventors," PIER Working Paper Archive 15-014, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
    12. Young-Don Cho & Hoo-Gon Choi, 2013. "Principal parameters affecting R&D exploitation of nanotechnology research: a case for Korea," Scientometrics, Springer;Akadémiai Kiadó, vol. 96(3), pages 881-899, September.
    13. Federica Bianco & Marica Venezia, 2019. "Features of R&D Teams and Innovation Performances of Sustainable Firms: Evidence from the “Sustainability Pioneers” in the IT Hardware Industry," Sustainability, MDPI, vol. 11(17), pages 1-19, August.
    14. Miguélez, Ernest & Moreno, Rosina, 2015. "Knowledge flows and the absorptive capacity of regions," Research Policy, Elsevier, vol. 44(4), pages 833-848.
    15. Audretsch, David & Braunerhjelm, Pontus & Acs, Zoltán J & Carlsson, Bo, 2005. "The Knowledge Spillover Theory of Entrepreneurship," CEPR Discussion Papers 5326, C.E.P.R. Discussion Papers.
    16. Ke Feng & Bas Karreman & Deming Zeng & Enrico Pennings, 2024. "R&D collaboration, social coordination, and standardization: evidence from the Chinese automotive industry," The Journal of Technology Transfer, Springer, vol. 49(1), pages 158-190, February.
    17. Neus Palomeras & Eduardo Melero, 2010. "Markets for Inventors: Learning-by-Hiring as a Driver of Mobility," Management Science, INFORMS, vol. 56(5), pages 881-895, May.
    18. Mounir Amdaoud & Christian Le Bas, 2020. "Patent Determinants for SMEs in Least-Developed Countries: How Enterprise Size Makes the Difference," Post-Print hal-03059446, HAL.
    19. Bell, Alex & Chetty, Raj & Jaravel, Xavier & Petkova, Neviana & Van Reenen, John, 2019. "Who becomes an inventor in America? The importance of exposure to innovation," LSE Research Online Documents on Economics 101434, London School of Economics and Political Science, LSE Library.
    20. Jiang, Lin & Clark, Brent B. & Turban, Daniel B., 2023. "Overcoming the challenge of exploration: How decompartmentalization of internal communication enhances the effect of exploration on employee inventive performance," Technovation, Elsevier, vol. 119(C).
    21. Gambardella, Alfonso, 2023. "Private and social functions of patents: Innovation, markets, and new firms," Research Policy, Elsevier, vol. 52(7).
    22. Chetty, Raj & Bell, Alex & Jaravel, Xavier & Petkova, Neviana & Van Reenen, John, 2019. "Do tax cuts produce more Einsteins? The impact of financial incentives vs. exposure to innovation on the supply of inventors," LSE Research Online Documents on Economics 102606, London School of Economics and Political Science, LSE Library.
    23. Nicole Ziegler & Frauke Ruether & Martin Bader & Oliver Gassmann, 2013. "Creating value through external intellectual property commercialization: a desorptive capacity view," The Journal of Technology Transfer, Springer, vol. 38(6), pages 930-949, December.
    24. d’Andria, Diego, 2016. "Why are researchers paid bonuses? On technology spillovers and market rivalry," Research Policy, Elsevier, vol. 45(10), pages 2105-2112.
    25. Thomas Åstebro & Pontus Braunerhjelm & Anders Broström, 2013. "Does academic entrepreneurship pay?," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 22(1), pages 281-311, February.
    26. Stéphane Maraut & Catalina Martínez, 2014. "Identifying author–inventors from Spain: methods and a first insight into results," Scientometrics, Springer;Akadémiai Kiadó, vol. 101(1), pages 445-476, October.
    27. Bronwyn H. Hall & Christian Helmers & Mark Rogers & Vania Sena, 2013. "The Importance (or not) of Patents to UK Firms," NBER Working Papers 19089, National Bureau of Economic Research, Inc.
    28. Fassio, Claudio & Geuna, Aldo & Rossi, Federica, 2014. "The Contribution of Academic Knowledge to the Value of Industry Inventions: Micro level evidence from patent inventors," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201422, University of Turin.
    29. Barberá-Tomás, David & Jiménez-Sáez, Fernando & Castelló-Molina, Itziar, 2011. "Mapping the importance of the real world: The validity of connectivity analysis of patent citations networks," Research Policy, Elsevier, vol. 40(3), pages 473-486, April.
    30. Liu, Li-jun & Cao, Cong & Song, Min, 2014. "China's agricultural patents: How has their value changed amid recent patent boom?," Technological Forecasting and Social Change, Elsevier, vol. 88(C), pages 106-121.
    31. Grid Thoma & Salvatore Torrisi & Alfonso Gambardella & Dominique Guellec & Bronwyn H. Hall & Dietmar Harhoff, 2010. "Harmonizing and Combining Large Datasets - An Application to Firm-Level Patent and Accounting Data," NBER Working Papers 15851, National Bureau of Economic Research, Inc.
    32. Kamal Saggi, 2016. "Trade, Intellectual Property Rights, and the World Trade Organization," Vanderbilt University Department of Economics Working Papers 16-00014, Vanderbilt University Department of Economics.
    33. Haeussler, Carolin & Colyvas, Jeannette A., 2011. "Breaking the Ivory Tower: Academic Entrepreneurship in the Life Sciences in UK and Germany," Research Policy, Elsevier, vol. 40(1), pages 41-54, February.
    34. Dushnitsky, Gary & Klueter, Thomas, 2017. "Which industries are served by online marketplaces for technology?," Research Policy, Elsevier, vol. 46(3), pages 651-666.
    35. Philippe Aghion & Ufuk Akcigit & Ari Hyytinen & Otto Toivanen, 2017. "The social origins of inventors," CEP Discussion Papers dp1522, Centre for Economic Performance, LSE.
    36. Thomas Zwick & Katharina Frosch, 2017. "Attenuation bias when measuring inventive performance," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 26(3), pages 195-201, April.
    37. Blind, Knut & Filipović, Ellen & Lazina, Luisa K., 2022. "Motives to Publish, to Patent and to Standardize: An Explorative Study Based on Individual Engineers’ Assessments," Technological Forecasting and Social Change, Elsevier, vol. 175(C).
    38. Julie Callaert & Maikel Pellens & Bart Looy, 2014. "Sources of inspiration? Making sense of scientific references in patents," Scientometrics, Springer;Akadémiai Kiadó, vol. 98(3), pages 1617-1629, March.
    39. Torrisi, Salvatore & Gambardella, Alfonso & Giuri, Paola & Harhoff, Dietmar & Hoisl, Karin & Mariani, Myriam, 2016. "Used, blocking and sleeping patents: Empirical evidence from a large-scale inventor survey," Research Policy, Elsevier, vol. 45(7), pages 1374-1385.
    40. OKADA, Yoshimi & 岡田, 吉美 & NAITO, Yusuke & 内藤, 祐介 & NAGAOKA, Sadao & 長岡, 貞男, 2017. "Impact of Patent Scope on subsequent Inventions: Findings from a new Measure," IIR Working Paper 17-03, Institute of Innovation Research, Hitotsubashi University.
    41. Higham, Kyle & de Rassenfosse, Gaétan & Jaffe, Adam B., 2021. "Patent Quality: Towards a Systematic Framework for Analysis and Measurement," Research Policy, Elsevier, vol. 50(4).
    42. Beugelsdijk, Sjoerd & Jindra, Björn, 2018. "Product innovation and decision-making autonomy in subsidiaries of multinational companies," Journal of World Business, Elsevier, vol. 53(4), pages 529-539.
    43. Claire Bonnard, 2011. "Les incitations à l'innovation dans le secteur privé," Post-Print halshs-00599700, HAL.
    44. Bodas Freitas , Isabel Maria & Geuna, Aldo & Lawson, Cornelia & Rossi, Federica, 2014. "How Industry Inventors Collaborate with Academic Researchers: The choice between shared and unilateral governance forms," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201402, University of Turin.
    45. Sachiko Kuroda & Isamu Yamamoto, 2009. "How are hours worked and wages affected by labor regulations?: The white-collar exemption and 'name-only managers' in Japan," Keio/Kyoto Joint Global COE Discussion Paper Series 2009-008, Keio/Kyoto Joint Global COE Program.
    46. Darcy, Jacques & Krämer-Eis, Helmut & Guellec, Dominique & Debande, Olivier, 2009. "Financing technology transfer," EIB Papers 10/2009, European Investment Bank, Economics Department.
    47. Braunerhjelm, Pontus & Svensson, Roger, 2007. "The Inventor’s Role: Was Schumpeter Right?," Working Paper Series 690, Research Institute of Industrial Economics.
    48. Jörn H. Block & Andreas Landgraf, 2016. "Transition from part-time entrepreneurship to full-time entrepreneurship: the role of financial and non-financial motives," International Entrepreneurship and Management Journal, Springer, vol. 12(1), pages 259-282, March.
    49. Hall, Bronwyn H., 2009. "The financing of innovative firms," EIB Papers 8/2009, European Investment Bank, Economics Department.
    50. John P. WALSH & NAGAOKA Sadao, 2009. "Who Invents?: Evidence from the Japan-U.S. inventor survey," Discussion papers 09034, Research Institute of Economy, Trade and Industry (RIETI).
    51. Nicola Bianchi & Michela Giorcelli, 2020. "Scientific Education and Innovation: From Technical Diplomas to University Stem Degrees [The Social Origins and IQ of Inventors]," Journal of the European Economic Association, European Economic Association, vol. 18(5), pages 2608-2646.
    52. Gaétan Rassenfosse, 2012. "How SMEs exploit their intellectual property assets: evidence from survey data," Small Business Economics, Springer, vol. 39(2), pages 437-452, September.
    53. Wesley M. Cohen & You-Na Lee & John P. Walsh, 2019. "How Innovative Are Innovations? A Multidimensional, Survey-Based Approach," NBER Chapters, in: Measuring and Accounting for Innovation in the Twenty-First Century, pages 139-182, National Bureau of Economic Research, Inc.
    54. Alfonso Gambardella & Dietmar Harhoff & Bart Verspagen, 2017. "The economic value of patent portfolios," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 26(4), pages 735-756, December.
    55. Neus Palomeras & David Wehrheim, 2021. "The strategic allocation of inventors to R&D collaborations," Strategic Management Journal, Wiley Blackwell, vol. 42(1), pages 144-169, January.
    56. Harhoff, Dietmar & Gambardella, Alfonso & Verspagen, Bart, 2008. "The Value of European Patents," CEPR Discussion Papers 6848, C.E.P.R. Discussion Papers.
    57. Dirk Czarnitzki & Katrin Hussinger & Bart Leten, 2020. "How Valuable are Patent Blocking Strategies?," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 56(3), pages 409-434, May.
    58. Dingler, Annika & Enkel, Ellen, 2016. "Socialization and innovation: Insights from collaboration across industry boundaries," Technological Forecasting and Social Change, Elsevier, vol. 109(C), pages 50-60.
    59. James B. Ang & Jakob B. Madsen, 2012. "Imitation Versus Innovation In An Aging Society: International Evidence Since 1870," Monash Economics Working Papers 45-12, Monash University, Department of Economics.
    60. You-Na Lee & John P. Walsh, 2012. "Intra-organizational integration and innovation: organizational structure, environmental contingency and R&D performance," ICER Working Papers 20-2011, ICER - International Centre for Economic Research.
    61. Haufler, Andreas & Persson, Lars & Norbäck, Pehr-Johan, 2012. "Entrepreneurial innovations and taxation," CEPR Discussion Papers 9157, C.E.P.R. Discussion Papers.
    62. Walsh, John P. & Lee, You-Na & Jung, Taehyun, 2016. "Win, lose or draw? The fate of patented inventions," Research Policy, Elsevier, vol. 45(7), pages 1362-1373.
    63. Diego d'Andria, 2016. "Employed inventors, inter-firm mobility, bonus pay with multi-stage R&D processes, and optimal innovation policy," JRC Working Papers on Taxation & Structural Reforms 2016-02, Joint Research Centre.
    64. Giummo, Jesse, 2014. "An examination of the intertemporal returns of patented inventions," Research Policy, Elsevier, vol. 43(8), pages 1312-1319.
    65. Zwick, Thomas & Frosch, Katharina & Hoisl, Karin & Harhoff, Dietmar, 2017. "The power of individual-level drivers of inventive performance," Research Policy, Elsevier, vol. 46(1), pages 121-137.
    66. Feldman, Maryann & Kenney, Martin & Lissoni, Francesco, 2015. "The New Data Frontier," Research Policy, Elsevier, vol. 44(9), pages 1629-1632.
    67. Hughes, A. & Mina, A., 2010. "The Impact of the Patent System on SMEs," Working Papers wp411, Centre for Business Research, University of Cambridge.
    68. Namgyoo K. Park & Monica Youngshin Chun & Jeonghwan Lee, 2019. "How Do Mobility Direction and Human Assets of Mobile Engineers Affect Joint Knowledge Creation after M&As?," Sustainability, MDPI, vol. 11(16), pages 1-21, August.
    69. Alberto Gherardini & Alberto Nucciotti, 2017. "Yesterday’s giants and invisible colleges of today. A study on the ‘knowledge transfer’ scientific domain," Scientometrics, Springer;Akadémiai Kiadó, vol. 112(1), pages 255-271, July.
    70. Ejermo, Olof & Toivanen, Hannes, 2018. "University invention and the abolishment of the professor's privilege in Finland," Research Policy, Elsevier, vol. 47(4), pages 814-825.
    71. Gill, Andrej & Heller, David, 2024. "Leveraging intellectual property: The value of harmonized enforcement regimes," Journal of Banking & Finance, Elsevier, vol. 163(C).
    72. Aldieri, Luigi & Sena, Vania & Vinci, Concetto Paolo, 2018. "Domestic R&D spillovers and absorptive capacity: Some evidence for US, Europe and Japan," International Journal of Production Economics, Elsevier, vol. 198(C), pages 38-49.
    73. Marino, Alba & Mudambi, Ram & Perri, Alessandra & Scalera, Vittoria G., 2020. "Ties that bind: Ethnic inventors in multinational enterprises’ knowledge integration and exploitation," Research Policy, Elsevier, vol. 49(9).
    74. Fontana, Roberto & Geuna, Aldo, 2009. "The Nature of Collaborative Patenting Activities," Department of Economics and Statistics Cognetti de Martiis LEI & BRICK - Laboratory of Economics of Innovation "Franco Momigliano", Bureau of Research in Innovation, Complexity and Knowledge, Collegio 200910, University of Turin.
    75. Victor Gilsing & Rudi Bekkers & Bodas Isabel Maria Freitas & Marianne van Der Steen, 2011. "Differences in technology transfer between science-based and development based industries: transfer mechanisms and barriers," Post-Print hal-01487500, HAL.
    76. Diego Useche & Ernest Miguelez & Francesco Lissoni, 2020. "Highly skilled and well connected: Migrant inventors in cross-border M&As," Post-Print hal-03097926, HAL.
    77. Xue Yang & Hao Zhang & Die Hu & Bingde Wu, 2023. "The timing dilemma: understanding the determinants of innovative startups’ patent collateralization for loans," Small Business Economics, Springer, vol. 60(1), pages 371-403, January.
    78. Elvira Cerver-Romero & João J. Ferreira & Cristina Fernandes, 2020. "A scientometric analysis of knowledge spillover research," The Journal of Technology Transfer, Springer, vol. 45(3), pages 780-805, June.
    79. Sarah Lasso & Emerson Mainardes & Fabio Motoki, 2019. "Why do entrepreneurs open tech startups? A comparative study between Brazilian and foreign enterprises," International Entrepreneurship and Management Journal, Springer, vol. 15(1), pages 233-255, March.
    80. Thomas Walter & Christoph Ihl & René Mauer & Malte Brettel, 2018. "Grace, gold, or glory? Exploring incentives for invention disclosure in the university context," The Journal of Technology Transfer, Springer, vol. 43(6), pages 1725-1759, December.
    81. Langinier, Corinne & Lluis, Stéphanie, 2015. "Departure and Promotion of U.S. Patent Examiners: Do Patent Characteristics Matter?," Working Papers 2015-18, University of Alberta, Department of Economics.
    82. Ernest Miguélez & Rosina Moreno & Jordi Suriñach, 2010. "Inventors on the move: Tracing inventors' mobility and its spatial distribution," Post-Print hal-03910248, HAL.
    83. Alessandra Scandura, 2013. "The role of scientific and market knowledge in the inventive process: evidence from a survey of industrial inventors," ERSA conference papers ersa13p128, European Regional Science Association.
    84. Henry Sauermann & Wesley M. Cohen, 2010. "What Makes Them Tick? Employee Motives and Firm Innovation," Management Science, INFORMS, vol. 56(12), pages 2134-2153, December.
    85. Bell, Alex & Chetty, Raj & Jaravel, Xavier & Petkova, Neviana & Van Reenen, John, 2019. "Joseph Schumpeter Lecture, EEA Annual Congress 2017: Do tax cuts produce more Einsteins? The impacts of financial incentives versus exposure to innovation on the supply of inventors," LSE Research Online Documents on Economics 104536, London School of Economics and Political Science, LSE Library.
    86. Paola Giuri & Rosa Grimaldi & Anna Kochenkova & Federico Munari & Laura Toschi, 2020. "The effects of university-level policies on women’s participation in academic patenting in Italy," The Journal of Technology Transfer, Springer, vol. 45(1), pages 122-150, February.
    87. Ruzzier Mitja & Nagy Tine & Ravnihar Robert, 2009. "Analyzing the Process of Patent Submission with a Special Emphasis on the Phases of the Research Process - the Case of Slovenia," Organizacija, Sciendo, vol. 42(5), pages 156-164, September.
    88. Stephane Lhuillery & Julio Raffo & Intan Hamdan-Livramento, 2016. "Measuring creativity: Learning from innovation measurement," WIPO Economic Research Working Papers 31, World Intellectual Property Organization - Economics and Statistics Division.
    89. Ejermo, Olof & Hansen, Høgni Kalsø, 2014. "How Important are Local Inventive Milieus: The role of Birthplace, High School and University Education," Papers in Innovation Studies 2014/15, Lund University, CIRCLE - Centre for Innovation Research.
    90. Nomaler, Onder & Verspagen, Bart, 2016. "River deep, mountain high: Of long-run knowledge trajectories within and between innovation clusters," MERIT Working Papers 2016-048, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    91. Giummo, Jesse, 2010. "German employee inventors' compensation records: A window into the returns to patented inventions," Research Policy, Elsevier, vol. 39(7), pages 969-984, September.
    92. Gambardella, Alfonso & Giuri, Paola & Luzzi, Alessandra, 2007. "The market for patents in Europe," Research Policy, Elsevier, vol. 36(8), pages 1163-1183, October.
    93. Gao, Kang & Yuan, Yijun, 2022. "Government intervention, spillover effect and urban innovation performance: Empirical evidence from national innovative city pilot policy in China," Technology in Society, Elsevier, vol. 70(C).
    94. Raquel Coelho Reis & Eduardo Gonçalves & Juliana Gonçalves Taveira & André Suriane da Silva & Pedro Vasconcelos do Amaral, 2023. "How do gatekeepers in networks influence the production of new knowledge? Evidence from Brazilian co‐invention networks," Regional Science Policy & Practice, Wiley Blackwell, vol. 15(9), pages 2046-2064, December.
    95. Bruno Cassiman & Giovanni Valentini, 2016. "Open innovation: Are inbound and outbound knowledge flows really complementary?," Strategic Management Journal, Wiley Blackwell, vol. 37(6), pages 1034-1046, June.
    96. Tartari, Valentina & Salter, Ammon, 2015. "The engagement gap:," Research Policy, Elsevier, vol. 44(6), pages 1176-1191.
    97. Bottazzi, Laura, 2009. "The role of venture capital in alleviating financial constraints of innovative firms," EIB Papers 9/2009, European Investment Bank, Economics Department.
    98. TSUKADA Naotoshi & NAGAOKA Sadao, 2011. "Standards as a Knowledge Source for R&D: A first look at their incidence and impacts based on the inventor survey and patent bibliographic data," Discussion papers 11018, Research Institute of Economy, Trade and Industry (RIETI).
    99. Walsh, John P. & Lee, You-Na & Nagaoka, Sadao, 2016. "Openness and innovation in the US: Collaboration form, idea generation and implementation," Research Policy, Elsevier, vol. 45(8), pages 1660-1671.
    100. Choi, Donghyuk & Kim, Yeonbae, 2018. "Market share and firms’ patent exploitation," Technovation, Elsevier, vol. 72, pages 13-23.
    101. Katrin Hussinger & Wunnam Basit Issah, 2022. "Trade Secret Protection and R&D Investment of Family Firms," DEM Discussion Paper Series 22-11, Department of Economics at the University of Luxembourg.
    102. John P. Walsh & Sadao Nagaoka, 2009. "How ’Open ’ is Innovation in the US and Japan?: Evidence from the RIETI-Georgia Tech inventor survey," Discussion papers 09022, Research Institute of Economy, Trade and Industry (RIETI).
    103. Sweet, Cassandra & Eterovic, Dalibor, 2019. "Do patent rights matter? 40 years of innovation, complexity and productivity," World Development, Elsevier, vol. 115(C), pages 78-93.
    104. Harhoff, Dietmar & Hoisl, Karin, 2007. "Institutionalized incentives for ingenuity--Patent value and the German Employees' Inventions Act," Research Policy, Elsevier, vol. 36(8), pages 1143-1162, October.
    105. Jussi Heikkilä, 2019. "IPR gender gaps: a first look at utility model, design right and trademark filings," Scientometrics, Springer;Akadémiai Kiadó, vol. 118(3), pages 869-883, March.
    106. Guan, Jiancheng & Zhang, Jingjing & Yan, Yan, 2015. "The impact of multilevel networks on innovation," Research Policy, Elsevier, vol. 44(3), pages 545-559.
    107. Elba Mauleón & María Bordons, 2010. "Male and female involvement in patenting activity in Spain," Scientometrics, Springer;Akadémiai Kiadó, vol. 83(3), pages 605-621, June.
    108. Powell, Walter W. & Giannella, Eric, 2010. "Collective Invention and Inventor Networks," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 575-605, Elsevier.
    109. So Young Kim & Eungdo Kim, 2018. "How Intellectual Property Management Capability and Network Strategy Affect Open Technological Innovation in the Korean New Information Communications Technology Industry," Sustainability, MDPI, vol. 10(8), pages 1-17, July.
    110. Peter T. Gianiodis & Gideon D. Markman & Andreas Panagopoulos, 2016. "Entrepreneurial universities and overt opportunism," Small Business Economics, Springer, vol. 47(3), pages 609-631, October.
    111. Alfonso Gambardella & Martin Ganco & Florence Honoré, 2015. "Using What You Know: Patented Knowledge in Incumbent Firms and Employee Entrepreneurship," Organization Science, INFORMS, vol. 26(2), pages 456-474, April.
    112. Herstad, Sverre J. & Sandven, Tore & Ebersberger, Bernd, 2015. "Recruitment, knowledge integration and modes of innovation," Research Policy, Elsevier, vol. 44(1), pages 138-153.
    113. Raffaele Conti & Alfonso Gambardella & Myriam Mariani, 2014. "Learning to Be Edison: Inventors, Organizations, and Breakthrough Inventions," Organization Science, INFORMS, vol. 25(3), pages 833-849, June.
    114. Ejermo, Olof & Jung, Taehyun, 2012. "Demographic patterns and trends in patenting: Gender, age, and education of inventors," Papers in Innovation Studies 2012/5, Lund University, CIRCLE - Centre for Innovation Research, revised 03 Apr 2012.
    115. Huang, Kenneth Guang-Lih & Huang, Can & Shen, Huijun & Mao, Hao, 2021. "Assessing the value of China's patented inventions," Technological Forecasting and Social Change, Elsevier, vol. 170(C).
    116. Tanya Araújo & Elsa Fontainha, 2018. "Are scientific memes inherited differently from gendered authorship?," Scientometrics, Springer;Akadémiai Kiadó, vol. 117(2), pages 953-972, November.
    117. Francesco Lissoni, 2013. "Intellectual property and university–industry technology transfer," Chapters, in: Faïz Gallouj & Luis Rubalcaba & Paul Windrum (ed.), Public–Private Innovation Networks in Services, chapter 7, pages 164-194, Edward Elgar Publishing.
    118. Huang, Can, 2012. "Estimates of the value of patent rights in China," MERIT Working Papers 2012-004, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    119. Harhoff, Dietmar, 2009. "The role of patents and licenses in securing external finance for innovation," EIB Papers 11/2009, European Investment Bank, Economics Department.
    120. Alfonso Gambardella & Pooyan Khashabi & Claudio Panico, 2020. "Managing Autonomy in Industrial Research and Development: A Project-Level Investigation," Organization Science, INFORMS, vol. 31(1), pages 165-181, January.
    121. Åstebro, Thomas & Thompson, Peter, 2011. "Entrepreneurs, Jacks of all trades or Hobos?," Research Policy, Elsevier, vol. 40(5), pages 637-649, June.
    122. Francesco SCHETTINO & Alessandro STERLACCHINI, 2007. "European Patenting and the Size of Inventors," Working Papers 308, Universita' Politecnica delle Marche (I), Dipartimento di Scienze Economiche e Sociali.
    123. Federico Moscatelli & Christian Chacua & Shreyas Gadgin Matha & Matte Hartog & Eduardo Hernandez Rodriguez & Julio Raffo & Muhammed A. Yildirim, 2024. "Can we map innovation capabilities?," WIPO Economic Research Working Papers 81, World Intellectual Property Organization - Economics and Statistics Division.
    124. Song, Haoyang & Hou, Jianhua & Zhang, Yang, 2022. "Catalytic capacity of technological innovation: Multidimensional definition and measurement from the perspective of knowledge spillover," Technology in Society, Elsevier, vol. 68(C).
    125. Hoenen, Sebastian & Kolympiris, Christos & Schoenmakers, Wilfred & Kalaitzandonakes, Nicholas, 2014. "The diminishing signaling value of patents between early rounds of venture capital financing," Research Policy, Elsevier, vol. 43(6), pages 956-989.
    126. Capponi, Giovanna & Criscuolo, Paola & Martinelli, Arianna & Nuvolari, Alessandro, 2019. "Profiting from innovation: Evidence from a survey of Queen's Awards winners," Structural Change and Economic Dynamics, Elsevier, vol. 49(C), pages 155-169.
    127. Svenja Jarchow & Andrea Röhm, 2019. "Patent-based investment funds: from invention to innovation," The Journal of Technology Transfer, Springer, vol. 44(2), pages 404-433, April.
    128. Alessandra Scandura, 2019. "The role of scientific and market knowledge in the inventive process: evidence from a survey of industrial inventors," The Journal of Technology Transfer, Springer, vol. 44(4), pages 1029-1069, August.
    129. Curdin Pfister & Miriam Koomen & Dietmar Harhoff & Uschi Backes-Gellner, 2016. "Regional Innovation Effects of Applied Research Institutions," Economics of Education Working Paper Series 0117, University of Zurich, Department of Business Administration (IBW), revised Jan 2021.
    130. Mohnen, Pierre, 2019. "R&D, innovation and productivity," MERIT Working Papers 2019-016, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
    131. Katharina Frosch, 2009. "Do only new brooms sweep clean? A review on workforce age and innovation," MPIDR Working Papers WP-2009-005, Max Planck Institute for Demographic Research, Rostock, Germany.
    132. Capponi, Giovanna & Martinelli, Arianna & Nuvolari, Alessandro, 2022. "Breakthrough innovations and where to find them," Research Policy, Elsevier, vol. 51(1).
    133. Kimberlee Weatherall & Elizabeth Webster, 2014. "Patent Enforcement: A Review Of The Literature," Journal of Economic Surveys, Wiley Blackwell, vol. 28(2), pages 312-343, April.
    134. Felix Poege & Dietmar Harhoff & Fabian Gaessler & Stefano Baruffaldi, 2019. "Science Quality and the Value of Inventions," Papers 1903.05020, arXiv.org, revised Apr 2019.
    135. Professor Bronwyn Hall, 2013. "The importance (or not) of patents to UK firms," National Institute of Economic and Social Research (NIESR) Discussion Papers 410, National Institute of Economic and Social Research.
    136. AndreÌ s LoÌ pez & Eugenia Orlicki, 2009. "Who Uses the Patent System in Developing Countries? A Study of Patent Propensities in Argentina, 1992-2001," Microeconomics Working Papers 22785, East Asian Bureau of Economic Research.
    137. Igna, Ioana A., 2018. "The effects of educational mismatch on inventor productivity. Evidence from Sweden, 2003-2010," Papers in Innovation Studies 2018/8, Lund University, CIRCLE - Centre for Innovation Research.
    138. Isabel Maria Bodas Freitas & Aldo Geuna & Federica Rossi, 2011. "University–Industry Interactions: The Unresolved Puzzle," Chapters, in: Cristiano Antonelli (ed.), Handbook on the Economic Complexity of Technological Change, chapter 11, Edward Elgar Publishing.
    139. Gambardella, Alfonso, 2013. "The economic value of patented inventions: Thoughts and some open questions," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 626-633.
    140. Nagaoka, Sadao & Motohashi, Kazuyuki & Goto, Akira, 2010. "Patent Statistics as an Innovation Indicator," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 2, chapter 0, pages 1083-1127, Elsevier.
    141. Kyle HIGHAM & NAGAOKA Sadao, 2022. "Language Barriers and the Speed of Knowledge Diffusion," Discussion papers 22074, Research Institute of Economy, Trade and Industry (RIETI).
    142. Mariachiara Barzotto & Giancarlo Corò & Ilaria Mariotti & Marco Mutinelli, 2019. "Ownership and workforce composition: a counterfactual analysis of foreign multinationals and Italian uni-national firms," Economia e Politica Industriale: Journal of Industrial and Business Economics, Springer;Associazione Amici di Economia e Politica Industriale, vol. 46(4), pages 581-607, December.
    143. Suzuki, Jun, 2011. "Structural modeling of the value of patent," Research Policy, Elsevier, vol. 40(7), pages 986-1000, September.
    144. Alessandro Comai, 2020. "A new approach for detecting open innovation in patents: the designation of inventor," The Journal of Technology Transfer, Springer, vol. 45(6), pages 1797-1822, December.

  13. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2004. "Dynamic competition in pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 175-182, May.

    Cited by:

    1. Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2005. "Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN," Working Papers CERM 01-2005, Competitività, Regole, Mercati (CERM).
    2. Patricia Laurens & Christian Le Bas & Antoine Schoen, 2019. "Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?," Post-Print hal-01725229, HAL.
    3. Massimo, Riccaboni & Jakub, Growiec & Fabio, Pammolli, 2011. "Innovation and Corporate Dynamics: A Theoretical Framework," MPRA Paper 30046, University Library of Munich, Germany.
    4. Katharina Elisabeth Fischer & Tom Stargardt, 2016. "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(8), pages 1027-1040, November.
    5. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Papers in Economics 11476, University of Munich, Department of Economics.
    6. Carl Blankart & Tom Stargardt & Jonas Schreyögg, 2011. "Availability of and Access to Orphan Drugs," PharmacoEconomics, Springer, vol. 29(1), pages 63-82, January.
    7. Chung, Sung Hoon & Kwon, Changhyun, 2016. "Integrated supply chain management for perishable products: Dynamics and oligopolistic competition perspectives with application to pharmaceuticals," International Journal of Production Economics, Elsevier, vol. 179(C), pages 117-129.
    8. Kanavos, Panos G. & Vandoros, Sotiris, 2011. "Determinants of branded prescription medicine prices in OECD countries," Health Economics, Policy and Law, Cambridge University Press, vol. 6(3), pages 337-367, July.
    9. Gonzalez, Jorge & Sismeiro, Catarina & Dutta, Shantanu & Stern, Philip, 2008. "Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules," International Journal of Research in Marketing, Elsevier, vol. 25(4), pages 247-260.
    10. Akaleephan, Chutima & Wibulpolprasert, Suwit & Sakulbumrungsil, Rungpetch & Luangruangrong, Paithip & Jitraknathee, Anchalee & Aeksaengsri, Achara & Udomaksorn, Siripa & Tangcharoensathien, Viroj & Ta, 2009. "Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: Analysis of the effect of TRIPs-Plus proposal," Health Policy, Elsevier, vol. 91(2), pages 174-182, July.
    11. Costa-i-Font, Joan & Varol, Nebibe & McGuire, Alistair, 2011. "Does pharmaceutical price regulation affect the adoption of generic competition?: evidence from the OECD, 1999-2008," LSE Research Online Documents on Economics 37537, London School of Economics and Political Science, LSE Library.
    12. Costa-Font, Joan & McGuire, Alistair & Varol, Nebibe, 2014. "Price regulation and relative delays in generic drug adoption," Journal of Health Economics, Elsevier, vol. 38(C), pages 1-9.
    13. Birg, Laura, 2013. "Pharmaceutical regulation and health policy objectives," University of Göttingen Working Papers in Economics 183, University of Goettingen, Department of Economics.
    14. Appelt, Silvia, 2010. "Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry," Discussion Paper Series of SFB/TR 15 Governance and the Efficiency of Economic Systems 357, Free University of Berlin, Humboldt University of Berlin, University of Bonn, University of Mannheim, University of Munich.
    15. Gonzalez, Jorge & Sismeiro, Catarina & Dutta, Shantanu & Stern, Philip, 2006. "Market Effects of Generic Entry: The Role of Physicians and of Non-Bioequivalent Competitors," MPRA Paper 3717, University Library of Munich, Germany, revised May 2007.
    16. Pieter Dylst & Steven Simoens, 2011. "Does the Market Share of Generic Medicines Influence the Price Level?," PharmacoEconomics, Springer, vol. 29(10), pages 875-882, October.
    17. Gianni Amisano & Maria Letizia Giorgetti, 2013. "Entry Into Pharmaceutical Submarkets: A Bayesian Panel Probit Analysis," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 28(4), pages 667-701, June.
    18. Iván Moreno-Torres & Jaume Puig-Junoy & Joan-Ramon Borrell, 2009. "Generic Entry into the Regulated Spanish Pharmaceutical Market," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 34(4), pages 373-388, June.
    19. Leopold, Christine & Mantel-Teeuwisse, Aukje Katja & Vogler, Sabine & de Joncheere, Kees & Laing, Richard Ogilvie & Leufkens, Hubert G.M., 2013. "Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries," Health Policy, Elsevier, vol. 112(3), pages 209-216.
    20. Magazzini Laura & Fabio Pammolli & Massimo Riccaboni, 2013. "R&D, Within and Between Patent Competition in the Pharmaceutical Industry," Working Papers 3/2013, IMT School for Advanced Studies Lucca, revised Jul 2013.
    21. Crowe, Bronwyn & Lindner, Bob & Llewellyn, Rick, 2006. "The benefits and beneficiaries of “public” investment in herbicide use research and development," 2006 Conference (50th), February 8-10, 2006, Sydney, Australia 174476, Australian Agricultural and Resource Economics Society.

  14. Fabio Pammolli & Laura Magazzini & Luigi Orsenigo, 2002. "The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis," Revue d'Économie Industrielle, Programme National Persée, vol. 99(1), pages 107-131.

    Cited by:

    1. Laura Magazzini & Fabio Pammolli & Gianluca Papa & Nicola Carmine Salerno, 2005. "Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN," Working Papers CERM 01-2005, Competitività, Regole, Mercati (CERM).
    2. Herrmann, Andrea M., 2008. "On the discrepancies between macro and micro level identification of competitive strategies," MPIfG Discussion Paper 08/6, Max Planck Institute for the Study of Societies.
    3. Gianluca Baio & Laura Magazzini & Antonio Nicita & Fabio Pammolli & Massimo Riccaboni, 2003. "Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato," Working Papers CERM 0-2003, Competitività, Regole, Mercati (CERM).
    4. Magazzini, Laura & Pammolli, Fabio & Riccaboni, Massimo, 2004. "Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure," MPRA Paper 15968, University Library of Munich, Germany.
    5. Patricia M. Danzon & Michael F. Furukawa, 2011. "Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets," NBER Working Papers 17226, National Bureau of Economic Research, Inc.
    6. Herrmann, Andrea M., 2008. "Choosing and successfully sustaining competitive strategies in the European pharmaceutical industry," MPIfG Discussion Paper 08/9, Max Planck Institute for the Study of Societies.
    7. Aidan Hollis, 2005. "How do Brands’ “Own Generics” Affect Pharmaceutical Prices?," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 27(4), pages 329-350, December.
    8. Laura Magazzini & Fabio Pammolli & Massimo Riccaboni, 2004. "Dynamic competition in pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 5(2), pages 175-182, May.
    9. Jean-Paul Moatti & Bruno Ventelou, 2009. "Économie de la santé dans les pays en développement des paradigmes en mutation," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 241-256.
    10. Herrmann, Andrea M. & Peine, Alexander, 2011. "When 'national innovation system' meet 'varieties of capitalism' arguments on labour qualifications: On the skill types and scientific knowledge needed for radical and incremental product innovations," Research Policy, Elsevier, vol. 40(5), pages 687-701, June.
    11. Leopold, Christine & Mantel-Teeuwisse, Aukje Katja & Vogler, Sabine & de Joncheere, Kees & Laing, Richard Ogilvie & Leufkens, Hubert G.M., 2013. "Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries," Health Policy, Elsevier, vol. 112(3), pages 209-216.

Chapters

    Sorry, no citations of chapters recorded.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.